The immunosuppressive effect of rapamycin on mouse small bowel transplantation

Transplantation

Volumn 61, Issue 4, 1996, Pages 523-526

  Chen, Huifang ^a,b   Qi, Shijie ^b   Xu, Dasheng ^b   Wu, Jiangping ^a,b   Daloze, Pierre ^b  

^a Fonds de la Rech en S du Quebec ^*  (Canada)

^b NOTRE DAME HOSPITAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; RAPAMYCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; GRAFT VERSUS HOST REACTION; IMMUNOSUPPRESSIVE TREATMENT; INTESTINE TRANSPLANTATION; MALE; MOUSE; NONHUMAN; ORAL DRUG ADMINISTRATION; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; SMALL INTESTINE; SURGICAL TECHNIQUE; SURVIVAL;

ANIMALS; CYCLOSPORINE; GRAFT SURVIVAL; IMMUNOSUPPRESSIVE AGENTS; INTESTINE, SMALL; MALE; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; POLYENES; SIROLIMUS;

EID: 0030006170     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007890-199602270-00001     Document Type: Article

References (39)

1. European Multicentre Trial Group. Cyclosporin in cadaveric renal transplantation: one year follow-up of a multicentre trial. Lancet 1983; 2: 986.
2. Miller LW, Pennington DG, McBride LR. Long-term effects of cyclosporine in cardiac transplantation. Transplant Proc 1990; 22(suppl 1): 15.
3. Kahan BD. Cyclosporine: a powerful addition to the immunosuppressive armamentarium. Am J Kidney Dis 1984; 3: 444.
4. Calne RY. Cyclosporin in cadaveric renal transplantation: 5-year follow-up of a multicentre trial. Lancet 1987; 2: 506.
5. Albrechtsen D, Berg KJ, Brekke I, et al. Renal replacement therapy in the cyclosporine era: results of a national transplantation program. Transplant Proc 1990; 22: 155.
6. Ponticelli C, Tarantino A, Montagnino G, et al. A randomized trial comparing triple-drug and double-drug therapy in renal transplantation. Transplantation 1988; 45: 913.
7. Lewis RM, Janney RP, Golden DL, et al. Stability of renal allogrft function associated with long-term cyclosporin immunosuppressive therapy - five year follow-up. Transplantation 1989; 47: 266.
8. Borel JF. Basic science summary. Transplant Proc 1988; 20(suppl): 722.
9. Canadian Multicentre Transplant Group. A randomized clinical trial of cyclosporine in cadaveric renal transplantation. N Engl J Med 1983; 309.
10. Beunett WM, Pulliam JP. Cyclosporine nephrotoxicity. Ann Intern Med 1983; 99: 851.
11. Bellet M, Cabrol C, Sassano P, et al. Systemic hypertension after cardiac transplantation-aldosterone system. Am J Cardiol 1985; 56: 1927.
12. Kumar MSA, White AG, Alex G et al. Correlation of blood levels and tissue level of cyclosporine with the histologic features of cyclosporin toxicity. Transplant Proc 1988; 20: 407.
13. Calne RY, Collier DSJ, Lim S, et al. Rapamycin for immunosuppression in organ allografting. Lancet 1989; 2: 227.
14. Morris RE, Meiser M. Identification of a new pharmacologic action for an old compound. Med Sci Res 1989; 17: 609.
15. Stepkowski SH, Chen H, Daloze P, Kahan B. Rapamycin, a potent immunosuppressive drug for vascularized heart, kidney, and small bowel allogrfats. Transplantation 1991; 52: 22.
16. Chen HF, Wu JP, Luo HY, Daloze PM. The immunosuppressive effect of rapamycin on pancreaticoduodenal transplants in the rat. Transplant Proc 1991; 23: 2239.
17. Chen H, Wu J, Luo H, Daloze P. Reversal of ongoing rejection of allografts by rapamycin. Transplant Proc 1991; 23: 2241.
18. Chen H, Wu J, Xu D, Luo H, Daloze P. Reversal of ongoing heart, kidney, and pancreas allograft rejection and suppression of accelerated heart allograft rejection in the rat by rapamycin. Transplantation 1993; 56: 651.
19. Lin CS, Boltz RC, Siekierka JJ, Sigal NH. FK506 and cyclosporin A inhibit highly similar signal transduction pathways in human T lymphocytes. Cell Immunol 1991; 133: 269.
20. Dumont FJ, Staruch MJ, Koprak SL, Melino MR, Sigal NH. Distinct mechanism of suppression of murine T cell activation by the related-macrolides FK506 and rapamycin. J Immunol 1990; 144: 251.
21. Luo H, Chen H, Daloze P, Chang J, Wu J. Inhibition of in vitro immunoglobulin production by rapamycin. Transplantation 1992; 53; 1071.
22. Chen H, Luo H, Daloze P, et al. Long-term in vivo effects of rapamycin on humoral and cellular immune responses in the rat. Immunobiology 1993; 188: 303.
23. Chen H, Wu J, Xu D, Aboujaoude M, Daloze P. The effect of rapamycin on orthotopic small bowel transplantation in the rat. Transplant Proc 1992; 24: 1157.
24. Chen H, Luo H, Daloze P, Xu D, Wu J. Rapamycin-induced long-term allograft survival depends on persistence of alloantigen. J Immunol 1994; 3107: 3118.
25. Grant D. Intestinal transplantation: current status. Transplant Proc 1989; 21: 2869.
26. Grant D, Wall W, Mimeault R, et al. Successful small-bowel/liver transplantation. Lancet 1990; 335: 181.
27. Todo S, Tzakis A, Abu-Elmagd K, et al. Cadaveric small bowel and small bowel-liver transplantation in humans. Transplantation 1992; 53: 369.
28. Zhong R, Zhang Z, Quan D, Duff J, Stiller C, Grant D. Development of a mouse intestinal transplantation model. Microsurgery 1993; 14: 141.
29. Squiers EC, Kelley SE, West JC. Small bowel transplantation in the mouse: development of a model. Microsurgery 1992; 13: 345.
30. Chen H, Xu D, Qi S, Wu J, Lu H, Daloze P. Rapamycin graft pretreatment in small bowel and kidney transplantation in the rat. Transplantation 1995; 59: 1084.
31. Garcia B, Zhong R, Wijsman J, et al. Pathological changes following intestinal transplantation in the rat. Transplant Proc 1990; 22: 2469.
32. Quan D, Grant D, Zhong R, Zhang Z, Garcia B, Jevnikar AN. Altered gene expression of cytokine, ICAM-1, and class II molecules precedes mouse intestinal allograft rejection. Transplantation 1994; 58: 808.
33. Grant D, Zhong R, Gunn H, et al. Graft-versus-host diseases associated with intestinal transplantation in the rat, host immune function and general histology. Transplantation 1989; 48: 545.
34. Zhong R, Zhang Z, Quan D, Garcia B, Duff J, Stiller C, Grant D. Intestinal transplantation in the mouse. Transplantation 1993; 56: 1034.
35. Lillehei RC, Gott B, Miller FA. The physiologic response of the small bowel of the dog to ischemia including prolonged in vitro presentation of the bowel with successful replacement and survival. Ann Surg 1959; 150: 543.
36. Grant D, Duff J, Zhong R, et al. Successful intestinal transplantation in pigs treated with cyclosporine. Transplantation 1988; 45: 279.
37. Monchik G, Russel P. Transplantation of small bowel in the rat: technical and immunological considerations. Surgery 1971; 70: 693.
38. Stepkowski SM, Chen H, Wang M, Daloze P, Kahan BD. Inhibition of host-versus-graft and graft-versus-host responses after small bowel transplantation in rats by rapamycin. Transplantation 1992; 53: 258.
39. Hiestand PC, Graber M, Hurtenbach U, et al. The new cyclosporine derivative, SDZ IMM 125: in vitro and in vivo pharmacologic effects. Transplant Proc 1992; 24(suppl 2): 31.